Gene · 5449
Papers2,504
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,504
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New Insights Into Implications of CTRP3 in Obesity, Metabolic Dysfunction, and Cardiovascular Diseases: Potential of Therapeutic Interventions. | Front Physiol | 2020 | 33343381 | PubTator, text mining | PubMed |
| Progress in the Pathogenesis, Diagnosis, and Treatment of TSH-Secreting Pituitary Neuroendocrine Tumor. | Front Endocrinol (Lausanne) | 2020 | 33329389 | PubTator, text mining | PubMed |
| Pituitary stalk interruption syndrome: A rare case report and literature review. | Medicine (Baltimore) | 2020 | 33327247 | PubTator, text mining | PubMed |
| The Interplay of WNT and PPARγ Signaling in Vascular Calcification. | Cells | 2020 | 33322009 | PubTator, text mining | PubMed |
| Growth Hormone Receptor Regulation in Cancer and Chronic Diseases. | Front Endocrinol (Lausanne) | 2020 | 33312162 | PubTator, text mining | PubMed |
| Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy. | Front Endocrinol (Lausanne) | 2020 | 33312158 | PubTator, text mining | PubMed |
| Pituitary stalk interruption syndrome and liver changes: From clinical features to mechanisms. | World J Gastroenterol | 2020 | 33311939 | PubTator, text mining | PubMed |
| The Enigma of Vascular Calcifications. | Kidney Int Rep | 2020 | 33306042 | PubTator, text mining | PubMed |
| Prognostic and Predictive Value of a 15 Transcription Factors (TFs) Panel for Hepatocellular Carcinoma. | Cancer Manag Res | 2020 | 33293862 | PubTator, text mining | PubMed |
| Gremlin-1 Promotes Metastasis of Breast Cancer Cells by Activating STAT3-MMP13 Signaling Pathway. | Int J Mol Sci | 2020 | 33287358 | PubTator, text mining | PubMed |
| Proteomic and Transcriptomic Analysis Identify Spliceosome as a Significant Component of the Molecular Machinery in the Pituitary Tumors Derived from POU1F1- and NR5A1-Cell Lineages. | Genes (Basel) | 2020 | 33261069 | PubTator, text mining | PubMed |
| Application of the RBBP9 Serine Hydrolase Inhibitor, ML114, Decouples Human Pluripotent Stem Cell Proliferation and Differentiation. | Int J Mol Sci | 2020 | 33256189 | PubTator, text mining | PubMed |
| Identifying transcriptomic correlates of histology using deep learning. | PLoS One | 2020 | 33237966 | PubTator, text mining | PubMed |
| G ATA2 mediates the negative regulation of the prepro-thyrotropin-releasing hormone gene by liganded T3 receptor β2 in the rat hypothalamic paraventricular nucleus. | PLoS One | 2020 | 33201916 | PubTator, text mining | PubMed |
| Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones. | Orphanet J Rare Dis | 2020 | 33176829 | PubTator, text mining | PubMed |
| JSRV Intragenic Enhancer Element Increases Expression from a Heterologous Promoter and Promotes High Level AAV-mediated Transgene Expression in the Lung and Liver of Mice. | Viruses | 2020 | 33172105 | PubTator, text mining | PubMed |
| Uremic Toxins Affecting Cardiovascular Calcification: A Systematic Review. | Cells | 2020 | 33172085 | PubTator, text mining | PubMed |
| Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors. | Sci Rep | 2020 | 33168897 | PubTator, text mining | PubMed |
| Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis. | Acta Neuropathol Commun | 2020 | 33168091 | PubTator, text mining | PubMed |
| The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology. | Front Endocrinol (Lausanne) | 2020 | 33162942 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5449/papers?page=44